Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections

被引:22
作者
Madani, Yasser [1 ]
Mann, Bhupinder [1 ]
机构
[1] W Middlesex Univ Hosp, Dept Resp Med, London TW7 6AF, England
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2012年 / 21卷 / 03期
关键词
nitrofurantoin; lung disease; drug-induced; fibrosis; urinary tract infection; prophylaxis; PULMONARY-FIBROSIS;
D O I
10.4104/pcrj.2012.00059
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nitrofurantoin is commonly used for the treatment and prophylaxis of recurrent urinary tract infections (UTIs). Although relatively rare, nitrofurantoin is one of the commonest causes of drug-induced pulmonary disease, which can be potentially serious and even fatal. Knowledge of such potential adverse effects is essential to enable early recognition and withdrawal of the drug. Patients on long-term nitrofurantoin should be reviewed and monitored regularly. Management involves early consideration of the condition, and prompt withdrawal of the drug. We report three cases of nitrofurantoin-induced lung disease in patients who were on long-term nitrofurantoin for UTI prophylaxis and present a brief review of the literature on this subject. (C) 2012 Primary Care Respiratory Society UK. All rights reserved. Y Madani and B Mann. Prim Care Respir J 2012; 21(3): 337-341 http://dx.doi.org/10.4104/pcrj.2012.00059
引用
收藏
页码:337 / 341
页数:5
相关论文
共 50 条
  • [1] NITROFURANTOIN-INDUCED LUNG DISEASE WITH FATAL OUTCOME: A CASE REPORT
    Rolfes, Caroline
    Dettmeyer, Reinhard
    Hochscheid, Christopher
    ROMANIAN JOURNAL OF LEGAL MEDICINE, 2021, 29 (03): : 336 - 338
  • [2] Rapid resolution of nitrofurantoin-induced interstitial lung disease
    Nunez Viejo, Miguel Angel
    Fernandez Montes, Ana
    Velasco Montes, Javier
    Javier Gomez-Roman, Jose
    Garcia Ibarbia, Carmen
    Hernandez Hernandez, Jose Luis
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (07): : 352 - 355
  • [3] Nitrofurantoin-induced lung disease:: about two cases
    Mrozek, N.
    Delevaux, I.
    Legendre, M.
    Andre, M.
    Trouillier, S.
    Voinchet, H.
    Aumaitre, O.
    REVUE DE MEDECINE INTERNE, 2008, 29 (02): : 149 - 151
  • [4] Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study
    ten Doesschate, Thijs
    Hendriks, Kelly
    van Werkhoven, Cornelis Henri
    van der Hout, Evelien C.
    Platteel, Tamara N.
    Groenewegen, Irene A. M.
    Muller, Anouk E.
    Hoepelman, Andy I. M.
    Bonten, Marc J. M.
    Geerlings, Suzanne E.
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (02) : 248 - 254
  • [5] Nitrofurantoin-induced lung- and hepatotoxicity
    Koulaouzidis, Anastasios
    Bhat, Shivaram
    Moschos, John
    Tan, Chew
    De Ramon, Ana
    ANNALS OF HEPATOLOGY, 2007, 6 (02) : 119 - 121
  • [6] Nitrofurantoin-induced immune-mediated lung and liver disease
    Schattner, A
    Von der Walde, J
    Kozak, N
    Sokolovskaya, N
    Knobler, H
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 317 (05) : 336 - 340
  • [7] Nitrofurantoin-induced immune-mediated lung and liver disease
    Milic, Rade
    Plavec, Goran
    Tufegdzic, Ivana
    Tomic, Ilija
    Sarac, Sanja
    Loncarevic, Olivera
    VOJNOSANITETSKI PREGLED, 2012, 69 (06) : 536 - 540
  • [8] History Is the Key to Diagnosis: A Case of Nitrofurantoin-Induced Interstitial Lung Disease
    Akopyan, Kristina
    Zafar, Raaed
    Faruqi, Ibrahim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [9] Recurrent acute nitrofurantoin-induced pulmonary toxicity
    Williams, EM
    Triller, DM
    PHARMACOTHERAPY, 2006, 26 (05): : 713 - 718
  • [10] Nitrofurantoin-Induced Lung Injury: A Reminder of an Overlooked Threat
    Suliman, Aasir M.
    Alamin, Mohammed A.
    Ul Haq, Irfan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)